share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  May 10 08:07

Gainers

  • Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million.
  • Novavax (NASDAQ:NVAX) shares rose 119.23% to $9.8. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today.
  • Sensus Healthcare (NASDAQ:SRTS) stock moved upwards by 51.18% to $5.76. The company's market cap stands at $94.4 million. As per the news, the Q1 earnings report came out yesterday.
  • Natera (NASDAQ:NTRA) shares moved upwards by 20.31% to $114.96. The market value of their outstanding shares is at $14.0 billion. The company's, Q1 earnings came out yesterday.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 16.25% to $2.79. The market value of their outstanding shares is at $15.2 million.
  • Guardant Health (NASDAQ:GH) shares moved upwards by 14.45% to $22.25. The market value of their outstanding shares is at $2.7 billion. The company's, Q1 earnings came out yesterday.

Losers

  • Macrogenics (NASDAQ:MGNX) shares declined by 67.0% to $4.84 during Friday's pre-market session. The market value of their outstanding shares is at $302.7 million. As per the press release, Q1 earnings came out yesterday.
  • Progyny (NASDAQ:PGNY) stock fell 25.54% to $24.2. The market value of their outstanding shares is at $2.3 billion. As per the press release, Q1 earnings came out yesterday.
  • Protalix BioTherapeutics (AMEX:PLX) shares decreased by 16.0% to $1.05. The company's market cap stands at $76.9 million. As per the news, the Q1 earnings report came out today.
  • Biofrontera (NASDAQ:BFRI) stock fell 14.56% to $1.35. The company's market cap stands at $6.8 million.
  • Alzamend Neuro (NASDAQ:ALZN) stock decreased by 9.84% to $0.53. The company's market cap stands at $3.6 million.
  • Gritstone Bio (NASDAQ:GRTS) shares declined by 9.54% to $0.88. The company's market cap stands at $94.2 million. The company's, Q1 earnings came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment